A new discovery shows how mutations in a novel gene, ANGPT2, cause primary lymphedema. This opens possibilities for the development of improved treatments of the disease. @helsinkiuni #HelsinkiHealth https://t.co/YSMNm3cgDO

— Academic Medical Center Helsinki (@amchelsinki) September 10, 2020 10:59